HIV/AIDS awareness workshop held in Pakistan

The International Herald Tribune's "Express Tribune" reports on a two-day HIV/AIDS awareness workshop held in Pakistan this week. Speaking on Monday at the inaugural session of the event, titled "The State of HIV in Pakistan-2011," Amir Maqbool, acting program manager of the National AIDS Control Program (NACP), stated that HIV/AIDS could not be controlled in the country without legislation and strong financial funding for prevention and control efforts, according to the newspaper. "In the aftermath of the devolution of the Ministry of Health, there is no mechanism to implement the legislation; something which previously fell under the purview of the Senate Standing Committee on Health," the newspaper notes. The article highlights findings from multiple studies presented at the workshop (Wasif, 1/10).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug